Results from a first-in-human study suggest this new-look device could provide cardiologists and their care teams with another way to treat tricuspid regurgitation in high-risk patients.

Despite an explosion in new AI tools available to assist radiologists in their work, there remains a paucity of options in the pediatric space. 

At least 11 patients have come forward regarding severe complications stemming from treatments and procedures completed by "Dr. Roxy."

ICAD Inc. said the deal spans multiple years and will see the nation’s largest radiology group adopting its breast  technology across the enterprise.

ACC Vice President Cathleen Dalton Biga, MSN, RN, will serve as the group's next president. Cardiologist Christopher Kramer, MD, will be its next vice president. 

The new rule on reporting work-related injuries and illnesses is set to take effect on January 1, 2024.

The civil rights probe follows a wrongful death lawsuit filed by Charles Johnson IV after the untimely death of his wife, who had undergone a planned cesarean section in 2016.

The FDA has categorized this as a Class I recall, meaning the use of these devices could cause “serious injuries or death.”

The agency is looking to lift the longstanding NCD that restricts patients to one amyloid-detecting positron emission tomography exam in their lifetime.

The new study, published in the Journal of the American College of Cardiology, focused on more than 500 patients treated with Abbott’s TriClip device in Europe.